In Re: Aimmune Therapeutics, Inc. Securities Litigation
Opinion
Trial Court Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA
IN RE AIMMUNE THERAPEUTICS, Case No. 20-cv-06733-MMC
INC. SECURITIES LITIGATION
ORDER DENYING DEFENDANTS’ RULE 12(c) MOTION FOR JUDGMENT ON THE PLEADINGS Re: Dkt. No. 85
12 Before the Court is the “Rule 12(c) Motion for Judgment on the Pleadings,” filed 13 August 31, 2022, by defendants Aimmune Therapeutics, Inc. and Jayson D.A. Dallas. 14 Plaintiffs Bruce Svitak, Barbara Carol Svitak, and Cecilia Pemberton have filed 15 opposition, to which the defendants have replied. The matter came on regularly for 16 hearing on November 18, 2022. Gregory Garre and Matthew Rawlinson of Latham & 17 Watkins LLP appeared on behalf of the defendants. Juan E. Monteverde and Miles 18 Dylan Schreiner of Monteverde & Associates, and Michael J. Palestina of Kahn Swick & 19 Foti, LLC, appeared on behalf of the plaintiffs. Having considered the parties’ respective 20 written submissions, as well as the arguments of counsel at the hearing, the Court,…